| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 0 | 0 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 292 | 0 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -292 | 0 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -292 | 0 | - | - | - | - | - | - | - | - |
| Employees | 0 | 0 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Lamazi Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | - | - | - | - | - | - | - |
| Current Assets | 7.399 | 7.323 | - | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | - | - | - | - | - | - | - | - |
| Receivables | 6.220 | 6.156 | - | - | - | - | - | - | - | - |
| Cash | 1.179 | 1.167 | - | - | - | - | - | - | - | - |
| Shareholders Funds | -6.489 | -6.423 | - | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | - | - | - | - | - |
| Debts | 13.888 | 13.746 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Lamazi Pharma Srl